Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepali Kumar

Showing results (191-200 of 231) with videos related to

Pageof 24
Sort By:
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
The Journal of Infectious Diseases|March 13, 2014
Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirusAdrian Egli, Aviad Levin, Deanna M Santer, et al.
The Lancet. Infectious Diseases|January 27, 2022
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trialDeepali Kumar, Michael G Ison, Jean-Paul Mira, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
The Journal of Infectious Diseases|December 23, 2016
Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ TransplantationSang Hoon Han, Deepali Kumar, Victor H Ferreira, et al.
The Lancet. Infectious Diseases|April 8, 2023
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimabJavier T Solera, Berta G Arbol, Victor H Ferreira, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2025
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort studyVictoria G Hall, Adrian A Alexander, Faranak Mavandadnejad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)Rueshandra Roosenhoff, Vaughan Reed, Andy Kenwright, et al.
Pageof 24

Showing results (191-200 of 231) with videos related to

Sort By:
Pageof 24
Journal of Cutaneous Medicine and Surgery|November 23, 2018
Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive TherapiesKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
Journal of the Canadian Association of Gastroenterology|October 17, 2019
Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive SummaryKim A Papp, Boulos Haraoui, Deepali Kumar, et al.
The Journal of Infectious Diseases|March 13, 2014
Immunomodulatory Function of Interleukin 28B during primary infection with cytomegalovirusAdrian Egli, Aviad Levin, Deanna M Santer, et al.
The Lancet. Infectious Diseases|January 27, 2022
Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trialDeepali Kumar, Michael G Ison, Jean-Paul Mira, et al.
Leukemia & Lymphoma|July 28, 2020
High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxisMaria Queralt Salas, Shruti Prem, Mats Remberger, et al.
Transplantation and Cellular Therapy|October 30, 2025
Herpes Zoster Frequency and Adjuvanted Recombinant Zoster Vaccination after Allogeneic Hematopoietic Cell TransplantationVictoria G Hall, Caden Chiarello, Mats Remberger, et al.
The Journal of Infectious Diseases|December 23, 2016
Human MicroRNA Responses Predict Cytomegalovirus Replication Following Solid Organ TransplantationSang Hoon Han, Deepali Kumar, Victor H Ferreira, et al.
The Lancet. Infectious Diseases|April 8, 2023
Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab-cilgavimabJavier T Solera, Berta G Arbol, Victor H Ferreira, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 28, 2025
Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort studyVictoria G Hall, Adrian A Alexander, Faranak Mavandadnejad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 28, 2019
Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)Rueshandra Roosenhoff, Vaughan Reed, Andy Kenwright, et al.
Pageof 24